Genetic Engineering

Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.

  • Engineered nucleases
  • Precision and efficiency of engineered nucleases
  • Targeted gene modification in plants

Related Conference of Genetic Engineering

August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 30-31, 2019

International Conference on Genetic Disorders

Bangkok, Thailand
September 13-14, 2019

12th World Congress on Cell & Tissue Science

Singapore
October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon | Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

| Lisbon, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA
May 21-22, 2020

24th European Biotechnology Congress

London,UK

Genetic Engineering Conference Speakers

Recommended Sessions

Related Journals

Are you interested in